68-5

80/120

) Ichikawa S, Gohda T, Murakoshi M, Li Z, Adachi E, Koshida T, Suzuki Y: Aspartic Acid Supplementation Ameliorates Symp‑toms of Diabetic Kidney Disease in Mice. FEBS Open Bio, 2020; 10: 1122-1134.) Hara K, Io H, Wakabayashi K, Maeda T, Kanda R, Nakata J, Maeda K, Sengoku H, Machida M, Kojima K, Sakamoto K, Tomino Y, Suzuki Y: Multicenter Laparoscopic Eval‑uation of the Peritoneum in Peritoneal Dial‑ysis Patients. Semin Dial, 2020; 33: 170-177.) Yokoyama H, Yamamamoto R, Imai E, Maruyama S, Sugiyama H, Nitta K, Tsuka‑moto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H,Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T,Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Furuichi K, Fujimoto K,Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y: Better remisshin rates in elderly Japanese patients with primary membranous nephropathy in nationwide real- world practice: The Japan Nephrotic Syndrome Cohort Study. (JNSCS). Clin Exp Nephrol, 2020; 24: 893-909.) Wu CY, Hua KF, Hsu WH, Suzuki Y, Chu LJ, Lee YC, Takahata A, Lee SL, Wu CC, Nikolic- Paterson DJ., Ka SM, Chen A: IgA Nephrop‑athy Benefits from Compound K Treatment by Inhibiting NF-κB/NLRP3 Inflammasome and Enhancing Autophagy and SIRT1. J Immunol, 2020; 205: 202-212. 3 4 5 6＊ 7) Takahata A, Arai S, Hiramoto E, Kitada K, Kato R, Makita Y, Suzuki H, Nakata J, Araki K, Miyazaki T, Suzuki Y: Crucial Role of AIM/CD5L in the Development of Glomer‑ular Inflammation in IgA Nephropathy. J Am Soc Nephrol, 2020; 31: 2013-2024.) Hirano K, Matsuzaki K, Yasuda T, Nishikawa M, Yasuda Y, Koike K, Maruyama S, Yokoo T, Matsuo S, Kawamura T, Suzuki Y: Associ‑ation Between Tonsillectomy and Outcomes 8530in Patients With Immunoglobulin A Nephrop‑athy. JAMA Netw Open, 2020; 2: e194772.) Io H, Nakata J, Inoshita H, Ishizaka M, Tomino Y, Suzuki Y: Relationship among Left Ventric‑ular Hypertrophy, Cardiovascular Events, and Preferred Blood Pressure Measurement Timing in Hemodialysis Patients. J Clin Med, 2020; 9: 3512-3521. 9† 10) Li Z, Murakoshi M, Ichikawa S, Koshida T, Adachi E, Suzuki C, Ueda S, Gohda T, Suzuki Y: The sodium-glucose cotransporter 2 inhib‑itor tofoglozin prevents diabetic kidney disease progression in type 2 diabetic mice. FEBS Open Bio, 2020; 10: 2761-2770.＊ 11) Kubo A, Hidaka T, Nakayama M, Sasaki Y, Takagi M, Suzuki H, Suzuki Y: Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases. BMC Nephrol, 2020; 21: 402-415. 12) Barbour SJ, Canney M, Coppo R, Zhang H, Liu ZH, Suzuki Y, Matsuzaki K, Katafuchi R, Induruwage D, Er L, Reich HN, Feehally J, Barratt J, Cattran DC; International IgA Nephropathy Network: Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool. Kidney Int, 2020; 98: 1009-1019.＊ 13) Shimizu Y, Nakata J, Yanagawa N, Shirotani Y, Fukuzaki H, Nohara N, Suzuki Y: Emer‑gent initiation of dialysis is related to an increase in both mortality and medical costs. Sci Rep, 2020; 10: 19638.＊ 14) Yabuuchi J, Ueda S, Yamagishi S, Nohara N, Nagasawa H, Wakabayashi K, Matsui T, Higashimoto Y, Kadoguchi T, Otsuka T, Gohda T, Suzuki Y: Assosiation of advanced glycation end products with sarcopenia and frailty in chronic kidney disease. Sci Rep, 2020; 10: 17647. 15) Mizutani K, Mikami R, Gohda T, Gotoh H, Aoyama N, Matsuyama Y, Kido D, Takeda K, Izumi Y, Sasaki Y, Iwata T: Poor oral hygiene and dental caries predict high mortality rate in hemodialysis: a 3-year cohort study. Sci Rep, 2020; 10: 21872. 16) Kuwasawa-Iwasaki M, Io H, Muto M, Ichikawa S, Wakabayashi K, Kanda R, Nakata J, Nohara N, Tomino Y, Suzuki Y: Effects of L-Carnitine